Dokument: Matched‐pair analysis of peri‐operative and oncological outcomes of robot‐assisted vs open retroperitoneal lymph node dissection

Titel:Matched‐pair analysis of peri‐operative and oncological outcomes of robot‐assisted vs open retroperitoneal lymph node dissection
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=69973
URN (NBN):urn:nbn:de:hbz:061-20250624-114520-0
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Pongratanakul, Pailin [Autor]
Vermeulen-Spohn, Marieke [Autor]
Wöltjen, Carolin [Autor]
Thy, Sophia [Autor]
Hiester, Andreas [Autor]
Albers, Peter [Autor]
Che, Yue [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]682,4 KB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 24.06.2025 / geändert 24.06.2025
Stichwörter:germ cell tumours, robot-assisted RPLND, testicular cancer, robotic surgery, oncological outcome, retroperitoneal lymph node dissection
Beschreibung:Objective
To analyse a comparatively large cohort of patients who underwent robot-assisted retroperitoneal lymph node dissection (R-RPLND) in a single centre, assessing the peri-operative and oncological safety of this procedure compared to that in a matched-pair cohort of patients who underwent open retroperitoneal lymph node dissection (O-RPLND).
Methods
We retrospectively identified 100 patients who underwent R-RPLND between October 2010 and January 2024. A matched-pair analysis of R-RPLNDs and O-RPLNDs was conducted based on the following criteria: surgical indication, histology, clinical stage (CS), and tumour size. The primary endpoint of this analysis was progression-free survival (PFS).
Secondary endpoints were peri-operative parameters.
Results
Based on surgical indication, the R-RPLND cohort was divided into four groups: CS II seminoma (Group 1, 42 patients); marker-negative CS II non-seminoma (Group 2, 15 patients); CS I non-seminoma with high-risk factors (Group 3, seven patients), and post-chemotherapy patients (Group 4, 34 patients). Two patients were excluded due to uncommon testicular
histology. With a mean follow-up of 32, 31, 32 and 28 months in the four groups, respectively, relapses occurred in 10/42 of Group 1, 3/15 of Group 2, and 1/7 of Group 3, while all patients remained relapse-free in Group 4. The matched-pair analysis revealed that histological retroperitoneal lymph node dissection specimens, relapse rates, and PFS were similar in the R-RPLND and O-RPLND groups. R-RPLND had advantages in terms of a shorter hospital stay as a surrogate for less morbidity.
Conclusion
In selected patients and selected surgical indications, R-RPLND represents a minimally invasive alternative to O-RPLND in
the management of patients with testicular germ cell tumours.
Rechtliche Vermerke:Originalveröffentlichung:
Pongratanakul, P., Vermeulen, M., Wöltjen, C., Thy, S., Hiester, A., Albers, P., & Che, Y. (2025). Matched‐pair analysis of peri‐operative and oncological outcomes of robot‐assisted vs open retroperitoneal lymph node dissection. BJU International, 136(1), 150–158. https://doi.org/10.1111/bju.16747
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:24.06.2025
Dateien geändert am:24.06.2025
english
Benutzer
Status: Gast
Aktionen